Cardinal Health, Inc. $CAH Shares Acquired by Total Wealth Planning & Management Inc.

Key Points

• Total Wealth Planning & Management Inc. significantly increased its stake in Cardinal Health by 231%, owning 15,900 shares valued at approximately $2.67 million after acquiring an additional 11,096 shares in the second quarter.
• Cardinal Health reported earnings of $2.08 EPS for the last quarter, beating the consensus estimate of $2.03 EPS, with quarterly revenue of $60.16 billion—a slight increase from the previous year.
• The company recently announced a quarterly dividend of $0.5107 per share, translating to an annualized dividend of $2.04 and a yield of 1.3%, with over 87% of the stock owned by institutional investors.

Total Wealth Planning & Management Inc. grew its position in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 231.0% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 15,900 shares of the company's stock after buying an additional 11,096 shares during the quarter. Cardinal Health accounts for 2.1% of Total Wealth Planning & Management Inc.'s holdings, making the stock its 6th largest holding. Total Wealth Planning & Management Inc.'s holdings in Cardinal Health were worth $2,671,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently bought and sold shares of the stock. MassMutual Private Wealth & Trust FSB increased its position in Cardinal Health by 3.6% during the 2nd quarter. MassMutual Private Wealth & Trust FSB now owns 1,767 shares of the company's stock worth $297,000 after purchasing an additional 62 shares during the period. Empirical Financial Services LLC d.b.a. Empirical Wealth Management grew its holdings in shares of Cardinal Health by 0.4% in the 2nd quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 17,805 shares of the company's stock worth $2,991,000 after acquiring an additional 69 shares during the period. Perigon Wealth Management LLC grew its holdings in Cardinal Health by 3.2% during the 2nd quarter. Perigon Wealth Management LLC now owns 2,314 shares of the company's stock valued at $389,000 after buying an additional 72 shares during the last quarter. Community Bank & Trust Waco Texas grew its holdings in Cardinal Health by 1.3% during the 2nd quarter. Community Bank & Trust Waco Texas now owns 5,598 shares of the company's stock valued at $940,000 after buying an additional 74 shares during the last quarter. Finally, Pinnacle Bancorp Inc. grew its holdings in Cardinal Health by 11.2% during the 1st quarter. Pinnacle Bancorp Inc. now owns 767 shares of the company's stock valued at $106,000 after buying an additional 77 shares during the last quarter. 87.17% of the stock is owned by institutional investors and hedge funds.

Cardinal Health Trading Down 0.3%

Shares of NYSE CAH opened at $157.24 on Friday. The stock has a 50 day simple moving average of $152.07 and a 200-day simple moving average of $150.92. The company has a market cap of $37.36 billion, a PE ratio of 24.38, a P/E/G ratio of 1.33 and a beta of 0.71. Cardinal Health, Inc. has a 12-month low of $106.98 and a 12-month high of $168.44.

Cardinal Health (NYSE:CAH - Get Free Report) last announced its earnings results on Tuesday, August 12th. The company reported $2.08 EPS for the quarter, topping the consensus estimate of $2.03 by $0.05. Cardinal Health had a negative return on equity of 74.45% and a net margin of 0.70%.The firm had revenue of $60.16 billion for the quarter, compared to analysts' expectations of $60.91 billion. During the same quarter in the previous year, the company earned $1.84 earnings per share. The firm's quarterly revenue was up .5% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. Sell-side analysts forecast that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, October 15th. Investors of record on Wednesday, October 1st will be issued a dividend of $0.5107 per share. The ex-dividend date of this dividend is Wednesday, October 1st. This represents a $2.04 annualized dividend and a yield of 1.3%. Cardinal Health's payout ratio is presently 31.63%.

Insider Buying and Selling

In other Cardinal Health news, CEO Jason M. Hollar sold 107,705 shares of the company's stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $148.90, for a total value of $16,037,274.50. Following the transaction, the chief executive officer owned 235,901 shares of the company's stock, valued at approximately $35,125,658.90. This represents a 31.35% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Jessica L. Mayer sold 38,078 shares of the company's stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total value of $5,666,767.96. Following the completion of the transaction, the insider directly owned 48,457 shares in the company, valued at $7,211,370.74. This represents a 44.00% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 271,676 shares of company stock valued at $40,489,525 in the last three months. Insiders own 0.12% of the company's stock.

Analysts Set New Price Targets

CAH has been the topic of a number of recent analyst reports. Wall Street Zen lowered Cardinal Health from a "strong-buy" rating to a "buy" rating in a research note on Saturday, August 2nd. Morgan Stanley reissued an "overweight" rating on shares of Cardinal Health in a research report on Tuesday, August 12th. Weiss Ratings reissued a "buy (b)" rating on shares of Cardinal Health in a research report on Wednesday. Jefferies Financial Group set a $150.00 target price on Cardinal Health in a research note on Tuesday, August 12th. Finally, Leerink Partners boosted their price objective on Cardinal Health from $186.00 to $187.00 and gave the company an "outperform" rating in a report on Monday. Twelve analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average price target of $166.00.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.